BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 11474017)

  • 1. Automated multiplex assay system for simultaneous detection of hepatitis B virus DNA, hepatitis C virus RNA, and human immunodeficiency virus type 1 RNA.
    Meng Q; Wong C; Rangachari A; Tamatsukuri S; Sasaki M; Fiss E; Cheng L; Ramankutty T; Clarke D; Yawata H; Sakakura Y; Hirose T; Impraim C
    J Clin Microbiol; 2001 Aug; 39(8):2937-45. PubMed ID: 11474017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA.
    McCormick MK; Dockter J; Linnen JM; Kolk D; Wu Y; Giachetti C
    J Clin Virol; 2006 Jul; 36(3):166-76. PubMed ID: 16427802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1, HCV and HBV seronegative window reduction by the new Roche cobas TaqScreen MPX test in seroconverting donors.
    Wiedmann M; Kluwick S; Walter M; Fauchald G; Howe J; Bronold M; Zauke M
    J Clin Virol; 2007 Aug; 39(4):282-7. PubMed ID: 17611148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
    Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
    Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical and clinical performance evaluation of the cobas TaqScreen MPX Test for use on the cobas s 201 system.
    Ohhashi Y; Pai A; Halait H; Ziermann R
    J Virol Methods; 2010 May; 165(2):246-53. PubMed ID: 20152864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations.
    Koppelman MH; Assal A; Chudy M; Torres P; de Villaescusa RG; Reesink HW; Lelie PN; Cuypers HT
    Transfusion; 2005 Aug; 45(8):1258-66. PubMed ID: 16078910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors.
    Japanese Red Cross NAT Screening Research Group
    Jpn J Infect Dis; 2000 Jun; 53(3):116-23. PubMed ID: 10957709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Roche cobas s 201 system and cobas TaqScreen multiplex test for blood screening: a European multicenter study.
    Jarvis L; Becker J; Tender A; Cleland A; Queiros L; Aquiar A; Azevedo J; Aprili G; Bressan F; Torres P; Nieto S; Ursitti A; Montoro J; Vila E; Ramada C; Saldanha J
    Transfusion; 2008 Sep; 48(9):1853-61. PubMed ID: 18513254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplex real-time quantitative RT-PCR assay for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1.
    Candotti D; Temple J; Owusu-Ofori S; Allain JP
    J Virol Methods; 2004 Jun; 118(1):39-47. PubMed ID: 15158067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infection.
    Nübling CM; Chudy M; Volkers P; Löwer J
    Transfusion; 2006 Nov; 46(11):1886-91. PubMed ID: 17076842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.
    Nantachit N; Thaikruea L; Thongsawat S; Leetrakool N; Fongsatikul L; Sompan P; Fong YL; Nichols D; Ziermann R; Ness P; Nelson KE
    Transfusion; 2007 Oct; 47(10):1803-8. PubMed ID: 17880604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of viral nucleic acid testing on contamination frequency of manufacturing plasma pools.
    Nübling CM; Unkelbach U; Chudy M; Seitz R
    Transfusion; 2008 May; 48(5):822-6. PubMed ID: 18208414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations.
    Phikulsod S; Oota S; Tirawatnapong T; Sakuldamrongpanich T; Chalermchan W; Louisirirotchanakul S; Tanprasert S; Chongkolwatana V; Kitpoka P; Phanuphak P; Wasi C; Nuchprayoon C;
    Transfusion; 2009 Jun; 49(6):1126-35. PubMed ID: 19392770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance characteristics of the AmpliScreen HIV-1 test, an assay designed for screening plasma mini-pools.
    Yang Y; Wisbeski MH; Mendoza M; Dorf S; Xu D; Nguyen M; Yeh S; Sun R
    Biologicals; 1999 Dec; 27(4):315-23. PubMed ID: 10686058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA.
    Margaritis AR; Brown SM; Seed CR; Kiely P; D'Agostino B; Keller AJ
    Transfusion; 2007 Oct; 47(10):1783-93. PubMed ID: 17880602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan.
    Mine H; Emura H; Miyamoto M; Tomono T; Minegishi K; Murokawa H; Yamanaka R; Yoshikawa A; Nishioka K;
    J Virol Methods; 2003 Sep; 112(1-2):145-51. PubMed ID: 12951223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panels.
    Assal A; Barlet V; Deschaseaux M; Dupont I; Gallian P; Guitton C; Morel P; van Drimmelen H; David B; Lelie N; De Micco P
    Transfusion; 2009 Feb; 49(2):301-10. PubMed ID: 19389212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of COBAS AmpliPrep nucleic acid extraction in conjunction with COBAS AmpliScreen HBV DNA, HCV RNA and HIV-1 RNA amplification and detection.
    Koppelman MH; Sjerps MC; Reesink HW; Cuypers HT
    Vox Sang; 2005 Nov; 89(4):193-200. PubMed ID: 16262751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microarray multiplex assay for the simultaneous detection and discrimination of hepatitis B, hepatitis C, and human immunodeficiency type-1 viruses in human blood samples.
    Hsia CC; Chizhikov VE; Yang AX; Selvapandiyan A; Hewlett I; Duncan R; Puri RK; Nakhasi HL; Kaplan GG
    Biochem Biophys Res Commun; 2007 May; 356(4):1017-23. PubMed ID: 17407765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fully automated quantitation of hepatitis B virus (HBV) DNA in human plasma by the COBAS AmpliPrep/COBAS TaqMan system.
    Hochberger S; Althof D; Gallegos de Schrott R; Nachbaur N; Röck H; Leying H
    J Clin Virol; 2006 Apr; 35(4):373-80. PubMed ID: 16461000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.